Of several thousand peptides presented by the major histocompatibility
molecule HLA-A2.1, at least nine are recognized by melanoma-specific
cytotoxic T lymphocytes (CTLs). Tandem mass spectrometry was used to i
dentify and to sequenceone of these peptide epitopes. Melanoma-specifi
c CTLs had an exceptionally high affinity for this nine-residue peptid
e, which reconstituted an epitope for CTL lines from each of five diff
erent melanoma patients tested. Recognition bymultiple CTL lines sugge
sts that this may be a promising candidate for use inpeptide-based mel
anoma vaccines.